Therapy for peripheral T-cell lymphomas: Where we are and where we hope to be Journal Article
| Authors: | Mehta-Shah, N; Horwitz, S. |
| Article Title: | Therapy for peripheral T-cell lymphomas: Where we are and where we hope to be |
| Abstract: | Our standard therapies for peripheral T-cell lymphoma may cure a subset of patients, and thus far novel agents have not changed the outcomes for the majority. © 2015, UBM Medica Healthcare Publications. All rights reserved. |
| Keywords: | signal transduction; unclassified drug; overall survival; drug approval; lung cancer; peripheral t cell lymphoma; t cell lymphoma; myelodysplastic syndrome; drug research; large cell lymphoma; romidepsin; pralatrexate; myeloproliferative neoplasm; belinostat; phosphatidylinositol 3 kinase inhibitor; anaplastic lymphoma kinase; clinical trial (topic); 2 oxoglutaric acid; crizotinib; angioimmunoblastic t cell lymphoma; brentuximab vedotin; isocitrate dehydrogenase 2; ruxolitinib; human; article; duvelisib; ag 221 |
| Journal Title: | Oncology (Norwalk) |
| Volume: | 29 |
| Issue: | 8 |
| ISSN: | 0890-9091 |
| Publisher: | C M P Medica LLC * The Oncology Group |
| Date Published: | 2015-08-15 |
| Start Page: | 558 |
| End Page: | 559 |
| Language: | English |
| PROVIDER: | scopus |
| PUBMED: | 26281839 |
| DOI/URL: | |
| Notes: | Export Date: 2 September 2015 -- Source: Scopus |
